|
|
|
|
|
by refurb
2641 days ago
|
|
Yeah, no. Regulators put no money into it other than what it costs to fund it's own regulatory process. And, under PDUFA, drug manufactures pay >$1M to fund the review of their drug. It's paid for by industry. Yes, clinical trials are often run by hospitals and universities, but manufacturers pay for everything. Drugs, people, etc. And you forgot to mention that failures are privatized too. Spend $500M on a trial that fails? That's not the public's money, that's investors money. |
|